A citation-based method for searching scientific literature

Inés Ibarra-Lecue, Rebeca Diez-Alarcia, Benito Morentin, J Javier Meana, Luis F Callado, Leyre Urigüen. Front Pharmacol 2020
Times Cited: 11







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced protein synthesis in schizophrenia patient-derived olfactory cells.
J A English, Y Fan, M Föcking, L M Lopez, M Hryniewiecka, K Wynne, P Dicker, N Matigian, G Cagney, A Mackay-Sim,[...]. Transl Psychiatry 2015
60
36

Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.
Radhika Chadha, James H Meador-Woodruff. Neuropsychopharmacology 2020
23
36

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.
Effat S Emamian, Diana Hall, Morris J Birnbaum, Maria Karayiorgou, Joseph A Gogos. Nat Genet 2004
721
36

Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.
Alessandra Bonito-Oliva, Simone Pallottino, Jesus Bertran-Gonzalez, Jean-Antoine Girault, Emmanuel Valjent, Gilberto Fisone. Neuropharmacology 2013
31
27

Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity.
Heather Bowling, Guoan Zhang, Aditi Bhattacharya, Luis M Pérez-Cuesta, Katrin Deinhardt, Charles A Hoeffer, Thomas A Neubert, Wen-biao Gan, Eric Klann, Moses V Chao. Sci Signal 2014
41
27

Schizophrenia.
Michael J Owen, Akira Sawa, Preben B Mortensen. Lancet 2016
827
27

Abnormalities of signal transduction networks in chronic schizophrenia.
Jennifer L McGuire, Erica A Depasquale, Adam J Funk, Sinead M O'Donnovan, Kathryn Hasselfeld, Shruti Marwaha, John H Hammond, Vahram Hartounian, James H Meador-Woodruff, Jarek Meller,[...]. NPJ Schizophr 2017
37
27

Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases.
Long Wang, Kai Zhou, Zhi Fu, Di Yu, Hesuyuan Huang, Xiaodong Zang, Xuming Mo. J Mol Neurosci 2017
80
27

mTOR complexes in neurodevelopmental and neuropsychiatric disorders.
Mauro Costa-Mattioli, Lisa M Monteggia. Nat Neurosci 2013
222
27

Current Concepts and Treatments of Schizophrenia.
Piotr Stępnicki, Magda Kondej, Agnieszka A Kaczor. Molecules 2018
147
27

mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
Radhika Chadha, Khaled Alganem, Robert E Mccullumsmith, James H Meador-Woodruff. Mol Psychiatry 2021
13
27

Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism.
Stefano Aringhieri, Shivakumar Kolachalam, Claudio Gerace, Marco Carli, Valeria Verdesca, Maria Giulia Brunacci, Chiara Rossi, Chiara Ippolito, Anna Solini, Giovanni U Corsini,[...]. Eur Neuropsychopharmacol 2017
31
18

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.
Juan F López-Giménez, Javier González-Maeso. Curr Top Behav Neurosci 2018
58
18


Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, Valeria Verdesca, Enrico Cini, Mario Rossi, Peter J McCormick, Giovanni U Corsini, Roberto Maggio, Marco Scarselli. Pharmacol Ther 2018
82
18

Biochemical Pathways Triggered by Antipsychotics in Human [corrected] Oligodendrocytes: Potential of Discovering New Treatment Targets.
Caroline Brandão-Teles, Valéria de Almeida, Juliana S Cassoli, Daniel Martins-de-Souza. Front Pharmacol 2019
11
18

Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia.
Michael R Barnes, Julie Huxley-Jones, Peter R Maycox, Mark Lennon, Amy Thornber, Fiona Kelly, Stewart Bates, Adam Taylor, Juliet Reid, Neil Jones,[...]. J Neurosci Res 2011
52
18

AMPK phosphorylation of raptor mediates a metabolic checkpoint.
Dana M Gwinn, David B Shackelford, Daniel F Egan, Maria M Mihaylova, Annabelle Mery, Debbie S Vasquez, Benjamin E Turk, Reuben J Shaw. Mol Cell 2008
18

Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function.
Anne Biever, Emmanuel Valjent, Emma Puighermanal. Front Mol Neurosci 2015
104
18

Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32.
Emmanuel Valjent, Jesus Bertran-Gonzalez, Heather Bowling, Sébastien Lopez, Emanuela Santini, Miriam Matamales, Alessandra Bonito-Oliva, Denis Hervé, Charles Hoeffer, Eric Klann,[...]. Neuropsychopharmacology 2011
51
18

Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.
N Kozlovsky, C Shanon-Weickert, E Tomaskovic-Crook, J E Kleinman, R H Belmaker, G Agam. J Neural Transm (Vienna) 2004
79
18

Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation.
Linda Panić, Sanda Tamarut, Melanie Sticker-Jantscheff, Martina Barkić, Davor Solter, Miljana Uzelac, Kristina Grabusić, Sinisa Volarević. Mol Cell Biol 2006
104
18


Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.
Stefano Fumagalli, Alessandro Di Cara, Arti Neb-Gulati, Francois Natt, Sandy Schwemberger, Jonathan Hall, George F Babcock, Rosa Bernardi, Pier Paolo Pandolfi, George Thomas. Nat Cell Biol 2009
246
18

Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia.
Mizuki Hino, Yasuto Kunii, Junya Matsumoto, Akira Wada, Atsuko Nagaoka, Shin-Ichi Niwa, Hitoshi Takahashi, Akiyoshi Kakita, Hiroyasu Akatsu, Yoshio Hashizume,[...]. J Psychiatr Res 2016
19
18

Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6.
S Volarevic, M J Stewart, B Ledermann, F Zilberman, L Terracciano, E Montini, M Grompe, S C Kozma, G Thomas. Science 2000
310
18


Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
S Prabakaran, J E Swatton, M M Ryan, S J Huffaker, J T-J Huang, J L Griffin, M Wayland, T Freeman, F Dudbridge, K S Lilley,[...]. Mol Psychiatry 2004
716
18

A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.
Liron Bar-Peled, Lynne Chantranupong, Andrew D Cherniack, Walter W Chen, Kathleen A Ottina, Brian C Grabiner, Eric D Spear, Scott L Carter, Matthew Meyerson, David M Sabatini. Science 2013
643
18

mTOR: from growth signal integration to cancer, diabetes and ageing.
Roberto Zoncu, Alejo Efeyan, David M Sabatini. Nat Rev Mol Cell Biol 2011
18

Modelling schizophrenia using human induced pluripotent stem cells.
Kristen J Brennand, Anthony Simone, Jessica Jou, Chelsea Gelboin-Burkhart, Ngoc Tran, Sarah Sangar, Yan Li, Yangling Mu, Gong Chen, Diana Yu,[...]. Nature 2011
928
18




5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.
Tiago A Mestre, Mateusz Zurowski, Susan H Fox. Expert Opin Investig Drugs 2013
39
9

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.
M J Arranz, J Munro, P Sham, G Kirov, R M Murray, D A Collier, R W Kerwin. Schizophr Res 1998
186
9

Clozapine as a Model for Antipsychotic Development.
Frederick C Nucifora, Marina Mihaljevic, Brian J Lee, Akira Sawa. Neurotherapeutics 2017
62
9

Interclass GPCR heteromerization affects localization and trafficking.
Rudy Toneatti, Jong M Shin, Urjita H Shah, Carl R Mayer, Justin M Saunders, Miguel Fribourg, Paul T Arsenovic, William G Janssen, Stuart C Sealfon, Juan F López-Giménez,[...]. Sci Signal 2020
14
9

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.
Pedro Casado, Edmund H Wilkes, Farideh Miraki-Moud, Marym Mohammad Hadi, Ana Rio-Machin, Vinothini Rajeeve, Rebecca Pike, Sameena Iqbal, Santiago Marfa, Nicholas Lea,[...]. Leukemia 2018
21
9

Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor.
Zoe Barclay, Louise Dickson, Derek Robertson, Melanie Johnson, Pamela Holland, Roberta Rosie, Liting Sun, Helen Jerina, Eve Lutz, Sue Fleetwood-Walker,[...]. Cell Signal 2013
3
33

A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases.
Deborah M Kurrasch-Orbaugh, Jason C Parrish, Val J Watts, David E Nichols. J Neurochem 2003
80
9


Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
D L Willins, S A Berry, L Alsayegh, J R Backstrom, E Sanders-Bush, L Friedman, B L Roth. Neuroscience 1999
117
9



Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.
Abbie G Anderson, Cullen B Gaffy, Joshua R Weseli, Kelly L Gorres. Viruses 2019
13
9

Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Christopher S Knauer, Jeffrey E Campbell, Christopher L Chio, Lawrence W Fitzgerald. Naunyn Schmiedebergs Arch Pharmacol 2009
17
9

Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.
Florence Gressier, Stefano Porcelli, Raffaella Calati, Alessandro Serretti. Eur Neuropsychopharmacol 2016
37
9

Mechanisms of signalling and biased agonism in G protein-coupled receptors.
Denise Wootten, Arthur Christopoulos, Maria Marti-Solano, M Madan Babu, Patrick M Sexton. Nat Rev Mol Cell Biol 2018
279
9

Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
Cullen L Schmid, Kirsten M Raehal, Laura M Bohn. Proc Natl Acad Sci U S A 2008
151
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.